Hostname: page-component-745bb68f8f-d8cs5 Total loading time: 0 Render date: 2025-01-09T08:49:37.525Z Has data issue: false hasContentIssue false
  • English
  • Français

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)

Published online by Cambridge University Press:  19 July 2023

L. Orsolini
L. Orsolini*
Affiliation:
Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, Polytechnic University of Marche, Ancona, Italy

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Abstract

Over the past twenty years a large number of new psychoactive substances (NPS) have entered and modified the recreational drug scene. Their intake has been associated with health-related risks, especially so for vulnerable populations such as people with severe mental illness, who might be at higher risk of suicidality or self-injurious behavior. The consumption and frequent poly-consumption of NPS result in death, suicide, serious self-injury behaviours as well as adverse effects on medical and mental health. Hence, the talk will deal with current data on suicidality and self-injury behaviours due to the use of NPS, particularly considering the suicide and self-injury risk due to the NPS intake among vulnerable people with preexisting severe mental illness.

Disclosure of Interest

None Declared

Type
Abstract
Information
European Psychiatry , Volume 66 , Special Issue S1: Abstracts of the 31st European Congress of Psychiatry , March 2023 , pp. S44
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.